The Effectiveness and Safety of Favipiravir in COVID-19 Hospitalized Patients at Tertiary Referral Hospital, Bali, Indonesia
COVID-19 is a major public health problem, with still questionable specific cure. Favipiravir is a COVID-19 antiviral that is potentially a therapy for COVID-19. This study aimed to analyze its effectivity and safety in moderate to critical hospitalized patients. This study was a retrospective cohor...
Main Authors: | Herni Damayanti, I Gede K Sajinadiyasa, Hindun Wilda Risni, Rani Sauriasari |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Indonesia
2021-11-01
|
Series: | Kesmas: Jurnal Kesehatan Masyarakat Nasional |
Subjects: | |
Online Access: | https://journal.fkm.ui.ac.id/kesmas/article/view/5433 |
Similar Items
-
Favipiravir in Therapy of Viral Infections
by: Ryta Łagocka, et al.
Published: (2021-01-01) -
Hematological Malignancy Patients, COVID-19, and Favipiravir
by: Rujittika Mungmunpuntipantip, et al.
Published: (2021-12-01) -
Safety Evaluation and Tolerability Overview of Favipiravir in the Management of COVID-19: A Real-Life Experience from Turkey
by: Ayşe Özlem Mete, et al.
Published: (2024-02-01) -
Cost-effectiveness of Favipiravir in moderately to severely ill COVID-19 patients in the real-world setting of Saudi arabian pandemic referral hospitals
by: Ahmad Alamer, et al.
Published: (2023-04-01) -
Evaluation of the effect of favipiravir on patients with COVID-19
by: Alireza Kamali, et al.
Published: (2023-01-01)